Reported Standalone quarterly numbers for Remedium Lifecare are:Net Sales at Rs 75.58 crore in March 2023 up 87.6% from Rs. 40.29 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 4.78 crore in March 2023 down 310.96% from Rs. 1.16 crore in March 2022.
EBITDA stands negative at Rs. 2.90 crore in March 2023 down 391.53% from Rs. 0.59 crore in March 2022.
Remedium Lifeca shares closed at 2,001.30 on May 30, 2023 (BSE) and has given 1,328.48% returns over the last 6 months and 1,366.15% over the last 12 months.
| Remedium Lifecare | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 75.58 | 176.48 | 40.29 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 75.58 | 176.48 | 40.29 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | 39.26 | | Purchase of Traded Goods | 71.87 | 170.29 | -- | | Increase/Decrease in Stocks | 1.71 | 3.14 | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.29 | 0.40 | 0.16 | | Depreciation | 0.01 | 0.01 | 0.02 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 4.61 | 1.12 | 1.45 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.91 | 1.52 | -0.61 | | Other Income | -- | 0.02 | 0.00 | | P/L Before Int., Excpt. Items & Tax | -2.91 | 1.54 | -0.61 | | Interest | -0.10 | 0.02 | 0.11 | | P/L Before Exceptional Items & Tax | -2.81 | 1.52 | -0.72 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -2.81 | 1.52 | -0.72 | | Tax | 1.97 | -- | 0.45 | | P/L After Tax from Ordinary Activities | -4.78 | 1.52 | -1.16 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.78 | 1.52 | -1.16 | | Equity Share Capital | 3.60 | 3.60 | 3.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -13.28 | 4.23 | -3.23 | | Diluted EPS | -13.28 | 4.23 | -3.23 | | EPS After Extra Ordinary | | Basic EPS | -13.28 | 4.23 | -3.23 | | Diluted EPS | -13.28 | 4.23 | -3.23 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
